Mehmet Salih Iyikesici

Assoc. Prof. Dr. Mehmet Salih İyikesici is a medical oncology specialist at Central Hospital in Istanbul. He specializes in Metabolic Supported Chemotherapy (MSCT) for treating breast and lung cancers. Dr. İyikesici published research on rectal cancer outcomes and metabolically supported therapies. These studies appear in several peer-reviewed journals.

Specialization and Oncology Approach

Dr. İyikesici treats patients with gastrointestinal, pancreatic, and colorectal cancers. He integrates chemotherapy with metabolic strategies to improve treatment results. This approach includes several supportive techniques:

• Metabolic Supported Chemotherapy (MSCT) — a method that combines traditional chemotherapy with metabolic interventions like fasting to target cancer cells
• Ketogenic diet protocols in cancer care
• Hyperthermia therapy — a treatment that uses heat to damage cancer cells and make them more sensitive to radiation
• Hyperbaric oxygen therapy — a process involving breathing pure oxygen in a pressurized chamber to help tissues heal

The physician also performs diagnostic evaluations using PET/CT and whole-body CT scans. He builds treatment plans for patients with early-stage and advanced malignancies. These plans include personalized supportive care based on specific patient needs.

Research and Academic Publications

Dr. İyikesici contributes to international scientific studies regarding patient outcomes and therapies. He has authored several peer-reviewed articles in national medical journals. Notable publications include:

• "Metabolic Supported Chemotherapy in Rectal Cancer" (2020)
• "NSCLC Patient Outcomes – Marmara University" (2004)
• "Early-Stage Breast Cancer Outcomes" (2004)

Professional Background

The doctor began his medical career in 1997. He currently serves as a Medical Oncology specialist at Central Hospital. This center treats 138,000 patients every year. He previously conducted clinical research at Marmara University regarding non–small cell lung cancer.